GlassScriptPhysician profile
Anirudh Gupta
NPI 1306259668
$2,692.07
in general payments reported to CMS, 2019-2025
22 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $437 · 2022: $60.39 · 2023: $1,180 · 2024: $827 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,978 · Education: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,977.59 |
| Education | $217.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $565.10 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $456.10 | 2023-2024 | |
| Amgen INC. | $314.01 | 2021-2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $171.51 | 2022-2023 | Soliris, Ultomiris |
| Grifols USA, LLC | $134.15 | 2021 | |
| Sk Life Science, INC. | $128.00 | 2023 | Xcopri |
| Neurocrine Biosciences, INC. | $123.90 | 2023-2024 | Ingrezza, Ongentys |
| Chiesi USA, INC. | $116.84 | 2021 | |
| Lilly USA, LLC | $111.76 | 2024 | Kisunla |
| Ucb, INC. | $106.32 | 2023-2024 | Zilbrysq, Rystiggo |
| Pfizer INC. | $81.62 | 2023 | |
| Celgene Corporation | $68.99 | 2023 | Zeposia |
| Csl Behring | $59.63 | 2023 | Hizentra |
| Idorsia Pharmaceuticals US INC | $57.80 | 2023 | Quviviq |
| Mdd US Operations, LLC | $37.90 | 2023 | Gocovri |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $29.88 | 2024 | Vumerity, Tysabri |
| Livanova USA, INC. | $25.08 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Ipsen Biopharmaceuticals, INC | $25.00 | 2024 | Dysport |
| Allergan, INC. | $24.24 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $23.32 | 2023 | Rexulti |
| Emd Serono, INC. | $17.17 | 2023 | Mavenclad |
| Abbott Laboratories | $13.75 | 2024 | Infinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anirudh Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.